Related Experiment Video
Updated: Jun 2, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small
Xiujie Xie1, H Patrick Macknight1, Amy L Lu1
1Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.
Abstract:
The CDKN2A gene, responsible for encoding the tumor suppressors p16(INK4A) and p14(ARF), is frequently inactivated in non-small cell lung cancer (NSCLC). Herein, an uncharacterized long non-coding RNA (lncRNA) (ENSG00000267053) on chromosome 19p13.12 was found to be overexpressed in NSCLC cells with an active, wild-type CDKN2A gene. This lncRNA, named cyclin-dependent kinase inhibitor 2A-regulated lncRNA (CyKILR), also correlated with an active WT STK11 gene, which encodes the tumor suppressor, liver kinase B1. CyKILR displayed two splice variants, CyKILRa (exon 3 included) and CyKILRb (exon 3 excluded), which are cooperatively regulated by CDKN2A and STK11 as knockdown of both tumor suppressor genes was required to induce a significant loss of exon 3 inclusion in mature CyKILR RNA. CyKILRa localized to the nucleus, and its downregulation using antisense RNA oligonucleotides enhanced cellular proliferation, migration, clonogenic survival, and tumor incidence. In contrast, CyKILRb localized to the cytoplasm, and its downregulation using small interfering RNA reduced cell proliferation, migration, clonogenic survival, and tumor incidence. Transcriptomics analyses revealed the enhancement of apoptotic pathways with concomitant suppression of key cell-cycle pathways by CyKILRa demonstrating its tumor-suppressive role. CyKILRb inhibited tumor suppressor miRNAs indicating an oncogenic nature. These findings elucidate the intricate roles of lncRNAs in cell signaling and tumorigenesis.
Insights
A novel long non-coding RNA, CyKILR, is overexpressed in non-small cell lung cancer (NSCLC) and exhibits distinct tumor-suppressive (CyKILRa) and oncogenic (CyKILRb) functions, regulated by CDKN2A and STK11 tumor suppressors.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Non-coding RNA Research
Background:
- The CDKN2A gene, encoding tumor suppressors p16(INK4A) and p14(ARF), is frequently inactivated in non-small cell lung cancer (NSCLC).
- Understanding the role of non-coding RNAs in cancer development is crucial for identifying new therapeutic targets.
Purpose of the Study:
- To characterize a novel long non-coding RNA (lncRNA) overexpressed in NSCLC cells with active CDKN2A.
- To elucidate the functional roles of different splice variants of this lncRNA in tumorigenesis.
Main Methods:
- Identification and naming of the lncRNA (CyKILR) and its splice variants (CyKILRa, CyKILRb).
- Analysis of CyKILR regulation by CDKN2A and STK11 tumor suppressor genes.
- Subcellular localization studies (nucleus for CyKILRa, cytoplasm for CyKILRb).
- Functional assays following knockdown of CyKILR variants (proliferation, migration, survival, tumor incidence).
- Transcriptomics to determine pathway involvement (apoptosis, cell cycle, miRNA regulation).
Main Results:
- CyKILR is overexpressed in NSCLC with wild-type CDKN2A and correlates with wild-type STK11.
- CDKN2A and STK11 cooperatively regulate CyKILR splicing, specifically exon 3 inclusion.
- CyKILRa (nuclear) knockdown enhanced proliferation, migration, survival, and tumor incidence.
- CyKILRb (cytoplasmic) knockdown reduced proliferation, migration, survival, and tumor incidence.
- CyKILRa promoted apoptosis and suppressed cell-cycle pathways; CyKILRb inhibited tumor suppressor miRNAs.
Conclusions:
- CyKILR exhibits dual roles in NSCLC, with CyKILRa acting as a tumor suppressor and CyKILRb as an oncogene.
- The expression and function of CyKILR variants are intricately linked to CDKN2A and STK11 status.
- This study reveals novel insights into lncRNA involvement in cancer cell signaling and tumorigenesis.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
lncRNA - Long Non-coding RNAs
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Types of RNA
RNA Performs Diverse...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

